Oppenheimer Maintains Outperform Rating on Pulse Biosciences, Sets $60 Target

Oppenheimer maintained its Outperform rating on Pulse Biosciences and a $60 price target. The target implies 14.4% upside from the Oct. 12 close of $52.45.